We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.37%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
SO
51
STRS Ohio
Ohio
$201M +$65.2M +314,820 +53%
RIM
52
RS Investment Management
California
$189M -$19.5M -94,285 -10%
BlackRock
53
BlackRock
New York
$181M +$56.6M +273,172 +51%
PHS
54
PFM Health Sciences
California
$174M -$52.3M -252,666 -24%
Ameriprise
55
Ameriprise
Minnesota
$164M +$15.2M +73,371 +11%
Two Sigma Investments
56
Two Sigma Investments
New York
$164M +$59.5M +287,568 +64%
Arrowstreet Capital
57
Arrowstreet Capital
Massachusetts
$162M +$62.7M +302,912 +72%
First Eagle Investment Management
58
First Eagle Investment Management
New York
$158M +$146M +706,833 New
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$156M -$6.73M -32,500 -4%
EPCM
60
Eton Park Capital Management
New York
$154M +$39.8M +192,000 +38%
CLG
61
Cooperman Leon G
$138M +$73.7M +355,826 +135%
Allianz Asset Management
62
Allianz Asset Management
Germany
$133M +$64.6M +312,145 +109%
AII
63
AGF Investments Inc
Ontario, Canada
$133M +$25.5M +123,212 +26%
Prudential Financial
64
Prudential Financial
New Jersey
$133M +$51.4M +248,256 +71%
UBS AM
65
UBS AM
Illinois
$129M -$4.68M -22,626 -4%
CCM
66
Conatus Capital Management
Connecticut
$120M +$111M +538,385 New
O
67
OrbiMed
New York
$119M +$7.66M +37,000 +7%
California Public Employees Retirement System
68
California Public Employees Retirement System
California
$118M -$5.28M -25,507 -5%
Renaissance Technologies
69
Renaissance Technologies
New York
$113M +$21.9M +105,789 +26%
HM
70
HealthCor Management
New York
$112M +$91M +439,300 +724%
FCM
71
Frontier Capital Management
Massachusetts
$111M -$35.3M -170,524 -26%
TA
72
Teachers Advisors
New York
$107M -$25.1M -121,166 -20%
DCM
73
Discovery Capital Management
Connecticut
$106M +$3.64M +17,570 +4%
TCSAM
74
Tyrus Capital S.A.M.
Monaco
$106M +$74.1M +357,900 +309%
GP
75
GLG Partners
United Kingdom
$105M -$14.1M -67,945 -13%

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.